Thomas Hermann
RNA as a Drug Target.
Education
1996 Ph.D., , Max-Planck-Institute for Biochemistry and Ludwig-Maximilians-University Munich, Germany
1992 Diploma, , University of Ulm, Germany
Appointments
2001-2005 Head, , Structural Chemistry Group, Anadys Pharmaceuticals, San Diego
1999-2000 Postdoc, , Memorial Sloan-Kettering Cancer Center, New York
1996-1998 Postdoc, , Institut de Biologie Moleculaire et Cellulaire, CNRS, Strasbourg, France
Awards and Academic Honors
1996-1998
EMBO Long-Term Fellow
1996
Otto-Hahn Medal of the Max-Planck Society, Germany
Research Interests
We are exploring the molecular recognition of ribonucleic acid (RNA) by small molecules. RNA molecules participate as key players in many biological processes and adopt complex architectures that are required for function. The development of ligands that bind specifically to RNA targets opens exciting new ways to expand greatly the existing repertoire of protein-directed therapeutics. We focus on four areas of research and apply diverse techniques, including molecular biology, biochemistry, X-ray crystallography as well as synthetic organic chemistry.Validation and Screening of New RNA Targets:We use molecular biological and biochemical methods to explore new RNA targets in two therapeutic areas: hepatitis C virus infection (HCV) and cancer. Screening assays are being developed that report on functional consequences of ligand binding to an RNA target in addition to returning binding affinity.Structure Determination of RNA Targets and Ligand Complexes:We use X-ray crystallography to investigate the three-dimensional architecture of RNA targets and their complexes with small molecules of both natural and synthetic origin.Design and Synthesis of New Ligands for RNA Targets:Structure-guided design is combined with ligand-based approaches to develop focused small molecule libraries for screening against RNA targets. We develop syntheses for new RNA-friendly molecules of natural product-like complexity.
Primary Research Area
Organic Chemistry
Interdisciplinary interests
Bioorganic
Macromolecular Structure
Synthesis
Selected Publications
- Chou FC, Sripakdeevong P, Dibrov SM, Hermann T, Das R, "Correcting pervasive errors in RNA crystallography through enumerative structure prediction.", Nat Methods, 2013, Vol. 10, Issue 1, 74-6
[View Abstract]
- Zhou S, Rynearson KD, Ding K, Brunn ND, Hermann T, "Screening for inhibitors of the hepatitis C virus internal ribosome entry site RNA.", Bioorg Med Chem, 2013,
[View Abstract]
- Brunn ND, Garcia Sega E, Kao MB, Hermann T, "Targeting a regulatory element in human thymidylate synthase mRNA.", Chembiochem, 2012, Vol. 13, Issue 18, 2738-44
[View Abstract]
- Dibrov SM, Ding K, Brunn ND, Parker MA, Bergdahl BM, Wyles DL, Hermann T, "Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches.", Proc Natl Acad Sci U S A, 2012, Vol. 109, Issue 14, 5223-8
[View Abstract]
- Dibrov S, McLean J, Hermann T, "Structure of an RNA dimer of a regulatory element from human thymidylate synthase mRNA.", Acta Crystallogr D Biol Crystallogr, 2011, Vol. 67, Issue Pt 2, 97-104
[View Abstract]
- Dibrov SM, McLean J, Parsons J, Hermann T, "Self-assembling RNA square.", Proc Natl Acad Sci U S A, 2011, Vol. 108, Issue 16, 6405-8
[View Abstract]
- Carnevali M, Parsons J, Wyles DL, Hermann T, "A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site.", Chembiochem, 2010, Vol. 11, Issue 10, 1364-7
[View Abstract]
- Dibrov SM, Parsons J, Hermann T, "A model for the study of ligand binding to the ribosomal RNA helix h44.", Nucleic Acids Res, 2010, Vol. 38, Issue 13, 4458-65
[View Abstract]
- Dutta S, Higginson CJ, Ho BT, Rynearson KD, Dibrov SM, Hermann T, "1,3-Diazepanes of natural product-like complexity from cyanamide-induced rearrangement of epoxy-delta-lactams.", Org Lett, 2010, Vol. 12, Issue 2, 360-3
[View Abstract]
- Parsons J, Castaldi MP, Dutta S, Dibrov SM, Wyles DL, Hermann T, "Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA.", Nat Chem Biol, 2009, Vol. 5, Issue 11, 823-5
[View Abstract]
- Dibrov SM, Johnston-Cox H, Weng YH, Hermann T, "Functional architecture of HCV IRES domain II stabilized by divalent metal ions in the crystal and in solution.", Angew Chem Int Ed Engl, 2007, Vol. 46, Issue 1-2, 226-9
[View Abstract]